1. Executive Summary
1.1. Global Stretch Marks Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Stretch Marks Treatment Market Outlook, 2018 - 2031
3.1. Global Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Topical Medications
3.1.1.1.1. Gels
3.1.1.1.2. Creams
3.1.1.1.3. Oils/Serums
3.1.1.2. Procedural Treatments
3.1.1.2.1. Radiofrequency Therapy
3.1.1.2.2. Non-ablative Laser Fractional Resurfacing
3.1.1.2.3. Ablative Laser Resurfacing
3.1.1.2.4. Infrared Devices/Radiations
3.1.1.2.5. Dermabrasion
3.1.1.2.6. Chemical Peels
3.2. Global Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Striae atrophicans (Thinned Skin)
3.2.1.2. Striae gravidarum (Post Pregnancy)
3.2.1.3. Striae distensae (Stretched Skin)
3.2.1.4. striae rubrae (Red)
3.2.1.5. Striae albae (White)
3.2.1.6. Striae nigra (Black)
3.2.1.7. Striae caerulea (Dark Blue)
3.3. Global Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Dermatology Clinics
3.3.1.3. Aesthetic Clinics
3.3.1.4. Wellness and Spa Centers
3.3.1.5. Home Care Settings
3.4. Global Stretch Marks Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Stretch Marks Treatment Market Outlook, 2018 - 2031
4.1. North America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Topical Medications
4.1.1.1.1. Gels
4.1.1.1.2. Creams
4.1.1.1.3. Oils/Serums
4.1.1.2. Procedural Treatments
4.1.1.2.1. Radiofrequency Therapy
4.1.1.2.2. Non-ablative Laser Fractional Resurfacing
4.1.1.2.3. Ablative Laser Resurfacing
4.1.1.2.4. Infrared Devices/Radiations
4.1.1.2.5. Dermabrasion
4.1.1.2.6. Chemical Peels
4.2. North America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Striae atrophicans (Thinned Skin)
4.2.1.2. Striae gravidarum (Post Pregnancy)
4.2.1.3. Striae distensae (Stretched Skin)
4.2.1.4. striae rubrae (Red)
4.2.1.5. Striae albae (White)
4.2.1.6. Striae nigra (Black)
4.2.1.7. Striae caerulea (Dark Blue)
4.3. North America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Dermatology Clinics
4.3.1.3. Aesthetic Clinics
4.3.1.4. Wellness and Spa Centers
4.3.1.5. Home Care Settings
4.4. North America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Stretch Marks Treatment Market Outlook, 2018 - 2031
5.1. Europe Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Topical Medications
5.1.1.1.1. Gels
5.1.1.1.2. Creams
5.1.1.1.3. Oils/Serums
5.1.1.2. Procedural Treatments
5.1.1.2.1. Radiofrequency Therapy
5.1.1.2.2. Non-ablative Laser Fractional Resurfacing
5.1.1.2.3. Ablative Laser Resurfacing
5.1.1.2.4. Infrared Devices/Radiations
5.1.1.2.5. Dermabrasion
5.1.1.2.6. Chemical Peels
5.2. Europe Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Striae atrophicans (Thinned Skin)
5.2.1.2. Striae gravidarum (Post Pregnancy)
5.2.1.3. Striae distensae (Stretched Skin)
5.2.1.4. striae rubrae (Red)
5.2.1.5. Striae albae (White)
5.2.1.6. Striae nigra (Black)
5.2.1.7. Striae caerulea (Dark Blue)
5.3. Europe Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Dermatology Clinics
5.3.1.3. Aesthetic Clinics
5.3.1.4. Wellness and Spa Centers
5.3.1.5. Home Care Settings
5.4. Europe Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Stretch Marks Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Topical Medications
6.1.1.1.1. Gels
6.1.1.1.2. Creams
6.1.1.1.3. Oils/Serums
6.1.1.2. Procedural Treatments
6.1.1.2.1. Radiofrequency Therapy
6.1.1.2.2. Non-ablative Laser Fractional Resurfacing
6.1.1.2.3. Ablative Laser Resurfacing
6.1.1.2.4. Infrared Devices/Radiations
6.1.1.2.5. Dermabrasion
6.1.1.2.6. Chemical Peels
6.2. Asia Pacific Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Striae atrophicans (Thinned Skin)
6.2.1.2. Striae gravidarum (Post Pregnancy)
6.2.1.3. Striae distensae (Stretched Skin)
6.2.1.4. striae rubrae (Red)
6.2.1.5. Striae albae (White)
6.2.1.6. Striae nigra (Black)
6.2.1.7. Striae caerulea (Dark Blue)
6.3. Asia Pacific Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Dermatology Clinics
6.3.1.3. Aesthetic Clinics
6.3.1.4. Wellness and Spa Centers
6.3.1.5. Home Care Settings
6.4. Asia Pacific Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Stretch Marks Treatment Market Outlook, 2018 - 2031
7.1. Latin America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Topical Medications
7.1.1.1.1. Gels
7.1.1.1.2. Creams
7.1.1.1.3. Oils/Serums
7.1.1.2. Procedural Treatments
7.1.1.2.1. Radiofrequency Therapy
7.1.1.2.2. Non-ablative Laser Fractional Resurfacing
7.1.1.2.3. Ablative Laser Resurfacing
7.1.1.2.4. Infrared Devices/Radiations
7.1.1.2.5. Dermabrasion
7.1.1.2.6. Chemical Peels
7.2. Latin America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.2.1.1. Striae atrophicans (Thinned Skin)
7.2.1.2. Striae gravidarum (Post Pregnancy)
7.2.1.3. Striae distensae (Stretched Skin)
7.2.1.4. striae rubrae (Red)
7.2.1.5. Striae albae (White)
7.2.1.6. Striae nigra (Black)
7.2.1.7. Striae caerulea (Dark Blue)
7.3. Latin America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Dermatology Clinics
7.3.1.3. Aesthetic Clinics
7.3.1.4. Wellness and Spa Centers
7.3.1.5. Home Care Settings
7.4. Latin America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Stretch Marks Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Topical Medications
8.1.1.1.1. Gels
8.1.1.1.2. Creams
8.1.1.1.3. Oils/Serums
8.1.1.2. Procedural Treatments
8.1.1.2.1. Radiofrequency Therapy
8.1.1.2.2. Non-ablative Laser Fractional Resurfacing
8.1.1.2.3. Ablative Laser Resurfacing
8.1.1.2.4. Infrared Devices/Radiations
8.1.1.2.5. Dermabrasion
8.1.1.2.6. Chemical Peels
8.2. Middle East & Africa Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Striae atrophicans (Thinned Skin)
8.2.1.2. Striae gravidarum (Post Pregnancy)
8.2.1.3. Striae distensae (Stretched Skin)
8.2.1.4. striae rubrae (Red)
8.2.1.5. Striae albae (White)
8.2.1.6. Striae nigra (Black)
8.2.1.7. Striae caerulea (Dark Blue)
8.3. Middle East & Africa Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Dermatology Clinics
8.3.1.3. Aesthetic Clinics
8.3.1.4. Wellness and Spa Centers
8.3.1.5. Home Care Settings
8.4. Middle East & Africa Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Treatment vs Stretch Mark Type Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Weleda
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Clarins
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. basq NYC
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Body Merry
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Himalaya Global Holdings Ltd.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Stratpharma AG (Stratpharma Inc.)
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Browne Drug Co., Inc. (Palmer’s)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Mederma (HRA Pharma)
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Givaudan SA
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Merz Pharma
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Unilever
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Bio-Oil (Union Swiss (Pty) Ltd)
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations